肉片牛帅帅
Lv3
220 积分
2021-01-12 加入
-
External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real World Data Sources
3天前
已完结
-
Fibrose pulmonaire idiopathique : recherche modèle désespérément
3天前
已完结
-
Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring Therapeutic Targets, and Advancements in Drug Delivery Strategies
3天前
已完结
-
Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
3天前
已完结
-
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
3天前
已完结
-
Imaging of Pulmonary Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis
3天前
已完结
-
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
4天前
已完结
-
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
4天前
已完结
-
Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]
11天前
已完结
-
NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage
11天前
已完结